Clinical Trial Update: Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

View source ↗

Summary

A pediatric heart transplant immunosuppression trial using microRNAs is currently recruiting to optimize therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Rejection
• Heart Failure

Snippet

Sponsor: Inova Health Care Services | Conditions: Cardiac Failure, Graft Rejection | Status: RECRUITING